Fast Track Initiative — Full Portfolio

NB Health Laboratory develops antibody therapeutics for drug discovery and development to address unmet medical needs in healthcare.

BiotechDeep TechHealthtechMedical DevicesTokyo, JP

KTKiyoshi Takayama(Founder and President)inJun Takasaki(VP/Chief Scientific Officer)髙山喜好(代表取締役)

PENTAS is a Japanese medical device company holding first-class medical device manufacturing and sales licenses as well as licenses to sell highly controlled medical devices.

HardwareHealthtechMedical DevicesKawasaki, JP

Tomohiko Kanai(代表取締役 (Representative Director))

BoardTeppei Banno(取締役 (Director))Taro Sato(取締役 (Director))Masaaki Sato(取締役 (Director))

Co-investorsXTXTech VenturesSPSpiral CapitalSPSpiral Innovation Partners

Qoly Corporation develops, manufactures, and sells microsurgery-assist robots and related products, using robotics to help surgeons perform precise and safe microsurgery for functional disorders.

HealthtechMedical DevicesRoboticsTokyo, JP

YKYohei Kuroda(Representative Director & President (Co-founder))inKazuhito Wakana(Director & CTO (Co-founder))Atsushi Miyamoto(Chief People Officer (Co-founder))Naoki Kobayashi(CFO)

Co-investorsDEDevelopment Bank of JapanMEMedVenture Partners, Inc.

A10 Lab Inc. develops みんチャレ (Minna Challenge), a behavioral change platform that leverages community support and technology to help users achieve health and wellness goals, particularly targeting lifestyle disease prevention and frailty prevention through mobile and business solutions.

ConsumerDigital HealthHealthtechWellness & FitnessTokyo, JP

長坂 剛(代表取締役 CEO兼COO)山口 信行(取締役 CTO)木下 謙一(取締役 CDO)

Co-investorsSUSUMITOMO LIFE INSURANCEMIMIRAI SOUZOU

Cellfiber is a biotechnology company founded in 2015 that develops cell encapsulation technology and manufacturing techniques to increase production capacity for cell and gene therapies, aiming to make these treatments accessible to more patients.

BiotechHardwareMedical DevicesKumamoto, JP

YYYu Yanagisawain

Co-investorsUNUntroD CapitalUNUniversal Materials Incubator

Combines single-cell RNA analysis technology from the Broad Institute with AI/ML models and large-scale clinical sample collection for novel drug discovery and precision medicine.

HealthtechCambridge, US

TKTariq Kassum(Executive Officer, Director)inMBMichael Boretti(Executive Officer)inCLChristoph Lengauer(Executive Officer, Director)in

Co-investorsCACatalio Capital Management, LPALAlexandriaCACasdin CapitalGVGV (Google Ventures)THThird Rock Ventures

FastDoctor operates a Japanese telemedicine and house-call service that connects patients with physicians through video consultations and in-home emergency visits, available nights, weekends, and year-round.

Digital HealthHealthtechMedical Devices

Co-investorsGLGlobis Capital PartnersKDKDDI Open Innovation Fund

Hatena is a Japanese social bookmarking and blogging platform that aggregates user-curated content and discussions.

Media & EntertainmentSocialTokyo, JP

Co-investorsINInclusion Japan

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.

BiotechDeep TechHealthtechLongevity

Co-investorsRERemiges Ventures, Inc.4B4BIO CapitalASAstellas Venture Management LLCAXAxil CapitalDCDCI Partners Co. Ltd.

Runs 'E-consult', an online specialist consultation service connecting primary physicians with expert specialists to help find undiagnosed rare-disease patients.

Co-investorsGLGlobis Capital Partners

mediPhone (メディフォン) is a medical interpretation and translation service for healthcare providers in Japan, combining AI machine translation (up to 107 languages) with remote phone/video interpretation by specialized medical interpreters (32 languages) and document translation.

AI & Machine LearningDigital HealthHealthtech

Co-investorsSOSony Ventures CorporationUTUTokyo Innovation Platform Co. Ltd.

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases.

BiotechDeep TechDigital HealthMedical DevicesTokyo, JP

有本 達(代表取締役 (Representative Director/CEO))

Co-investorsANAngel Bridge Co.,Ltd.RERed CapitalKEKeio Innovation InitiativeNINippon Venture CapitalTHThe Gogin Capital

NIL Co., Ltd. develops botanical-derived hair and scalp care products, including color treatments and scalp essences.

ConsumerDirect to ConsumerHealthtechNew MaterialsWellness & FitnessEbina, JP

Satokura Sato(Honorary Advisor (founder in 2015))佐藤正晃(Representative Director / CEO)Masaaki Sato(Representative Director, President & CEO)Hisashi Okada(Director & CTO)

Co-investorsALAlumni VenturesCOCourtside VenturesFLFlyover CapitalMYMyriad VenturesSCScrum VenturesSESerra Ventures+2 more

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

BiotechDeep TechMedical Devices

Michael McCullar, PhD(Chief Executive Officer)James Ahlers(Chief Financial Officer)Marty Giedlin, PhD(Chief Technology Officer)Tony Hurley(Chief Technical Operations Officer)SKSteve Kanner, PhD(Chief Scientific Officer)

Co-investorsGLGlobal BrainKYKyoto University Innovation CapitalUTUTECMIMitsubishi UFJ Capital

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsASAstellas Venture Management LLCF-F-Prime CapitalJIJIC Venture Growth InvestmentsKYKyoto University Innovation CapitalEQEQT Life Sciences

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical Devices

Co-investorsCACambridge Innovation CapitalM M VenturesPFPfizer Venture InvestmentsSESeroba Life SciencesTATaiho Ventures, LLCUTUTokyo Innovation Platform Co. Ltd.+1 more

Varinos develops and provides genetic testing services applying genome technology, including a uterine microbiome (endometrial flora) test used in fertility and reproductive medicine.

BiotechDigital HealthFemTechMedical DevicesTokyo, JP

桜庭 喜行(Founder & Chairman (former CEO))長井 陽子(Co-founder)Sakuraba(CEO)YSYoshiyuki Sakuraba(Founder)inYoko Nagai(Founder)in齊藤 洋一(代表取締役CEO)

Co-investorsANAngel Bridge Co.,Ltd.MIMIRAI SOUZOUMIMiyako CapitalSOSony Ventures Corporation

AccuRna develops drug delivery systems for nucleic acid therapeutics, including antisense oligonucleotides, siRNA, miRNA, and mRNA-based treatments.

AI & Machine LearningBiotechDeep TechMedical Devices

Shiro Akinaga(Chairman of the board, CEO)Keiko Hattori(Director, CEO)

BoardKazunori Kataoka(Project Professor of Policy Alternatives Research Institute at the University of Tokyo, Director General at Innovation Center of NanoMedicine)Keiji Itaka(Professor of Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University, Principal Research Scientist and Laboratory Head at Innovation Center of NanoMedicine)Nobuhiro Nishiyama(Professor of Laboratory for Chemistry and Life Science at Tokyo Institute of Technology, Principal Research Scientist and Laboratory Head at Innovation Center of NanoMedicine)Kanjiro Miyata(Associate Professor of Department of Materials Engineering at the University of Tokyo)

Co-investorsUTUTokyo Innovation Platform Co. Ltd.

Alivexis is a drug discovery company that develops small molecule therapeutics targeting cancer, immune-inflammatory conditions, and rare diseases, leveraging computational platforms and disease biology expertise across operations in Japan and the US.

AI & Machine LearningBiotechDeep TechTokyo, JP

SRS. Roy Kimura(Cofounder & CEO)inKOKazuki Ohno(Cofounder & COO)

Co-investorsSMSMBC Venture CapitalDBDBJ CapitalMOMobile Internet Capital, Inc.UTUTokyo Innovation Platform Co. Ltd.

Ichirou operates a caregiving workforce sharing platform and provides home care support and facility referral services for the elderly care market in Japan.

B2B MarketplacesDigital HealthHealthtechHR TechTokyo, JP

Co-investorsDGDG IncubationGLGlobal BrainMPMPowerOPOpen Network Lab

Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis.

BiotechDeep TechDigital HealthTsuruoka, JP

Taku Nakahara(代表取締役社長CEO (President & CEO))Jun Terauchi(CSO)

Co-investorsDEDentsu VenturesGLGlobal BrainMIMIRAI SOUZOUNINippon Venture Capital

AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.

AI & Machine LearningBiotechDeep TechHealthtechStanford, US

TSThorsten Stafforst(Chairman of the Board of Directors)inKEKris ElveruminTBTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in

BoardRodger Novak(Chair)in

Co-investors+N+ND CapitalARARCH Venture PartnersFOForbionVEVenrockNENextech InvestNONovalis LifeSciences+2 more

Shimane University biotech using high-purity mesenchymal stem cells (REC) for safe, effective stem cell therapy, with AI-based cell quality management.

Hide Takahashiin

Developing innovative drugs for aging-related diseases by targeting inflammatory senescent cells.

Co-investorsUTUTokyo Innovation Platform Co. Ltd.

Allm uses information and communication technology to address healthcare disparities and mismatches, aiming to provide equitable medical and welfare services to all people.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSaaS

Co-investorsASAsia Africa Investment & Consulting (AAIC)EIEisai Innovation, Inc.

Transferred to Carna Biosciences, Inc. in October 2013.

VELDT Inc. develops xCausal®, a causal AI (white-box) platform and Causal AI Assistant that estimate cause-and-effect relationships in data so businesses can understand the reasons behind AI decisions and simulate the impact of actions.

AI & Machine LearningData & InfrastructureEnterprise SoftwareTokyo, JP

Jin Nonogami(Founder)野々上 仁(代表取締役 CEO)安西 智宏(取締役)上田谷 真一(取締役)

Co-investorsACAccord VenturesMOMonozukuri Ventures

EditGene is an educational resource that explains modern genome and gene editing technologies, including CRISPR-based systems, base editing, prime editing, RNA editing, and AI-guided genome engineering.

BiotechEdTech

Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs.

BiotechHealthtech

Co-investorsSMSMBC Venture Capital

Japanese healthcare startup (Mental Health Technologies, Inc.) that runs businesses in mental health solutions, medical workforce shift services, medical career support, and digital marketing, centered on connecting companies with physicians to address employees' physical and mental health.

Digital HealthHealthtechMental HealthSaaSTokyo, JP

刀禰真之介(代表取締役社長 (Founder & President/CEO))

Co-investorsSKSkyland Ventures

Yukashikado provides personalized nutrition testing and customized supplement products tailored to individual nutritional needs.

ConsumerDigital HealthHealthtechWellness & FitnessTokyo, JP

Shinya Minobe(Representative Director & CEO)Daisuke Terada(Director, Vice President & CTO)